PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake

Published:2020-05-15 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zhang Jian-ye,Yan Yan-yan,Li Jia-jun,Adhikari Rameshwar,Fu Li-wu

Funder

National Natural Science Foundation of China

Guangdong Science and Technology Department

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference119 articles.

1. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study;Antonia;Lancet Oncol.,2016

2. Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial;Atkins;Lancet Oncol.,2018

3. Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study;Bang;Gastric Cancer,2019

4. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells;Blank;Cancer Res.,2004

5. 24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer;Borghaei;J. Thorac. Oncol.,2019

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymeric PD1/PDL1 Bispecific Antibody Enhances Immune Checkpoint Blockade Therapy;Materials Today Bio;2024-09

2. Atypical artificial cells: Novel biomimetic materials for combating cancer;Interdisciplinary Materials;2024-07-17

3. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights;Frontiers in Immunology;2024-07-16

4. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer;Cancer Management and Research;2024-07

5. Shedding Light on the Role of Exosomal PD-L1 (ExoPD-L1) in Cancer Progression: an Update;Cell Biochemistry and Biophysics;2024-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3